Author:
Dadu Razvan T.,Nambi Vijay,Ballantyne Christie M.
Reference80 articles.
1. Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med. 1986;314(8):488–500. Epub 1986/02/20.
2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–8. Epub 2005/06/29.
3. Kolodgie FD, Virmani R, Burke AP, Farb A, Weber DK, Kutys R, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004;90(12):1385–91. Epub 2004/11/18.
4. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient—Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98(2A):2H–15. Epub 2006/07/18.
5. Paramo JA, Rodriguez Ja JA, Orbe J. Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients. Biomark Insights. 2007;1:165–73. Epub 2007/01/01.